A. LaHood

Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

L. Trippa, P. Zimetbaum, B. D. de Jong, 2021, Trials.

Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review

C. Mitnick, G. Velásquez, C. Zeng, 2022, Journal of clinical medicine.

Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru

M. Tovar, L. Lecca, M. Franke, 2023, Open forum infectious diseases.

Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different

C. Mitnick, L. McKenna, A. LaHood, 2022, PLoS ONE.